Comparing two treatments for low white blood cells during breast cancer therapy
Treatments studied
Part of Cancer, Skin clinical trials.
This study compares two medications—Shengbai Oral Liquid and Leucogen Tablets—to help raise white blood cell counts in breast cancer patients whose counts drop during cancer treatment. Both drugs aim to help your body recover faster and allow you to continue your cancer therapy on schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–80 years old and have been diagnosed with breast cancer (confirmed by tissue biopsy)
- You developed moderate low white blood cell count (grade II–III neutropenia) while receiving cancer drugs and plan to continue that same treatment for at least 2 more cycles
- Your overall health allows you to continue cancer treatment, with adequate liver, kidney, heart, and lung function
- You have not participated in another new drug trial in the past 4 weeks and are not planning to join another trial during this study
- You have never had bone marrow radiation, stem cell transplant, or bone marrow transplant
- You do not have uncontrolled infections, severe heart/lung/liver/kidney disease, or blood disorders that cause low white cells
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Leucogen can prevent neutropenia (low white blood cells) caused by ribociclib, a targeted therapy for hormone receptor-positive, HER2-negative early breast cancer. It may help you stay on treatment without delays or dose reductions.
This study examines tiny particles in your blood from breast cancer cells to better predict which treatments will work best for you. Researchers will collect blood samples and a small tissue sample to understand your cancer's characteristics and help doctors choose more effective therapy.
This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.
This study looks at whether a common side effect (bone pain) from a medicine that boosts white blood cells (called G-CSF) is related to the number of neutrophils (a type of white blood cell) in your blood. If you join, you will receive the medicine as part of your normal chemotherapy routine, and the researchers will track your blood counts and any bone pain you experience.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This study compares different doses of a medication called PEG-rhG-CSF, which is used to help prevent a serious side effect of chemotherapy called febrile neutropenia (fever with a low white blood cell count). The goal is to find the best dose that keeps your blood counts healthy and reduces the risk of infection during treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.